FFA
SION

Farther Finance Advisors’s Sionna Therapeutics SION Stock Holding History

Farther Finance Advisors’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.62K Hold
196
– – ﹤0.01% 4523
2026
Q1 		$8.1K Buy
196
+6
+3% +$229 ﹤0.01% 4238
2025
Q4 		$7.82K Buy
+190
New +$7.21K ﹤0.01% 4069

Other funds holding SION

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Farther Finance Advisors's SION Position: Q2 2026 in Review

Farther Finance Advisors held its Sionna Therapeutics (SION) position steady in Q2 2026 at 196 shares worth $8.62K. The position accounts for ﹤0.01% of the portfolio, ranked #4523.

Farther Finance Advisors first reported a position in SION in Q4 2025 and has held it in 3 quarters since. 17 funds tracked by Wall St. Rank hold SION as of Q2 2026.

  • Farther Finance Advisors held 196 shares of Sionna Therapeutics worth $8.62K as of Q2 2026.
  • Farther Finance Advisors left its Sionna Therapeutics share count unchanged in Q2 2026.
  • Sionna Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4523 holding.
  • Farther Finance Advisors first reported a position in Sionna Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 17 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.